Ann: BrainChip Marks Significant Milestone, page-30

Just playing some games with the numbers it would appear that if BRN had 1 billion shares on issue then the dilution would be 53.2 cents for every thousand shares held. If the income generated per year turns out to be the $5,000,000 as predicted then the return on the 1000 shares in the first year would be $5.00.

In addition due to the NDA's and leads etc; about which ordinary shareholders know very little if anything there can be no doubt that those who have received these shares would be unable for some considerable time to sell same without being investigated for insider trading and as such these new shares are effectively in escrow.

As this is the case the shares they have received carry a potential future value to the holder tied to the success or otherwise of the company and would in the normal course provide a significant incentive to ensure that the company's fortunes continue to improve so that the share price and their wealth increases.

* * *

On another matter I have no idea whether a capital raising will be required to complete the development and roll out of AKIDA as all the statements from the company to date are against it, but if it is I think it would serve BRN well to reward existing shareholders by including them in such capital raising.

I know that I would love a chance to participate if the capital raising was for the purpose of bringing the test chip into the market place rather than watch private equity profit after all the faith which retail investors in Australia have placed in this technology. After all we constantly hear the company talking about the loyalty being shown by its Australian shareholders and loyalty is not a one way street.

Perhaps this is something which those who post on here might give some consideration too and perhaps formulate a plan to encourage the company to follow this course.